May 28

Scientists pinpoint how non-alcoholic fatty liver disease increases risk of vascular diseases

A team of researchers led by NTU scientists have discovered why patients with non-alcoholic fatty liver disease (NAFLD) are at higher risk of cardiovascular disease, thus shedding light on why the leading cause of mortality in NAFLD patients is cardiovascular complications instead of liver damage. The researchers found that NAFLD prompts the over-production of a […]

Apr 21

Can wearables track the severity of COVID symptoms?

Fitness trackers can tell you how well you’re sleeping, how fast you’re walking and, of course, how many steps you’ve taken. But during the pandemic, researchers have also investigated the ability of smart watches to help detect COVID-19 or provide data on recovery. The latest study uses several measures of heart rate data to help […]

Apr 6

More Evidence that COVID ‘brain fog’ is biologically based

FROM AAN 2022 Patients with persistent cognitive impairment months after illness with mild COVID-19 have higher levels of inflammatory markers in their cerebrospinal fluid (CSF). Researchers found elevated levels of CSF immune activation and immunovascular markers in individuals with cognitive postacute sequelae of SARS-CoV-2 infection (PASC). Patients whose cognitive symptoms developed during the acute phase […]

Mar 8

Antibody-Activated Endothelial Cells Increase the Risk of Blood Clots with Covid-19

By: William A. Haseltine Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots. The activity of antiphospholipid antibodies may help explain hypercoagulation associated with late stages of […]